{"DataElement":{"publicId":"6773707","version":"1","preferredName":"Lymphoma Subtype Classification Category","preferredDefinition":"Information related to the subtype classification category of lymphoma.","longName":"6773706v1.0:6773700v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6773706","version":"1","preferredName":"Lymphoma Subtype Classification","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._A group forming a type within a larger type._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"2475110v1.0:3078417v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2475110","version":"1","preferredName":"Lymphoma","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003","longName":"C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11901624-1EB2-3055-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-04-16","modifiedBy":"ONEDATA","dateModified":"2006-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3078417","version":"1","preferredName":"Subtype Classification","preferredDefinition":"Subtype; a group forming a type within a larger type.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C25696:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85381EC9-9080-4293-E040-BB89AD433DAC","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-04-27","modifiedBy":"ONEDATA","dateModified":"2010-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6AF255-0871-492F-E053-F662850A2696","latestVersionIndicator":"Yes","beginDate":"2019-06-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-03","modifiedBy":"MORENOC","dateModified":"2019-11-05","changeDescription":"11/5/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6773700","version":"1","preferredName":"Lymphoma Subtype Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"6773700v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"DEL","valueDescription":"Double-Expressor Lymphoma","ValueMeaning":{"publicId":"6773702","version":"1","preferredName":"Double-Expressor Lymphoma","longName":"6773702","preferredDefinition":"A diffuse large B-cell lymphoma characterized by double expression of MYC and BCL2 proteins without MYC and BCL2 gene aberrations. These lymphomas may have a worse prognosis than other diffuse large B-cell lymphomas, not otherwise specified, but they are not as aggressive as the high-grade B-cell lymphomas, with rearrangements of MYC and BCL2 and/or BCL6 genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Double-Expressor Lymphoma","conceptCode":"C138899","definition":"A diffuse large B-cell lymphoma characterized by double expression of MYC and BCL2 proteins without MYC and BCL2 gene aberrations. These lymphomas may have a worse prognosis than other diffuse large B-cell lymphomas, not otherwise specified, but they are not as aggressive as the high-grade B-cell lymphomas, with rearrangements of MYC and BCL2 and/or BCL6 genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6AE344-70C1-6D00-E053-F662850A60A5","latestVersionIndicator":"Yes","beginDate":"2019-06-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-03","modifiedBy":"ONEDATA","dateModified":"2019-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A6AE344-70DA-6D00-E053-F662850A60A5","beginDate":"2019-06-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-03","modifiedBy":"ONEDATA","dateModified":"2019-06-03","deletedIndicator":"No"},{"value":"DHL","valueDescription":"High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements","ValueMeaning":{"publicId":"6773704","version":"1","preferredName":"High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements","longName":"6773704","preferredDefinition":"A rare B-cell non-Hodgkin lymphoma that is characterized by the abnormal rearrangement of two genes, MYC gene and either BCL2 or BCL6 genes. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements","conceptCode":"C125904","definition":"High-grade B-cell lymphoma characterized by the abnormal rearrangement of two genes, MYC gene and either BCL2 or BCL6 genes. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6AE344-70E7-6D00-E053-F662850A60A5","latestVersionIndicator":"Yes","beginDate":"2019-06-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-03","modifiedBy":"ONEDATA","dateModified":"2019-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A6AE344-7100-6D00-E053-F662850A60A5","beginDate":"2019-06-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-03","modifiedBy":"ONEDATA","dateModified":"2019-06-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6AE344-70A8-6D00-E053-F662850A60A5","latestVersionIndicator":"Yes","beginDate":"2019-06-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-03","modifiedBy":"MORENOC","dateModified":"2019-11-05","changeDescription":"11/5/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Lymphoma subtype","type":"Preferred Question Text","description":"Lymphoma subtype","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6AA653-EEBC-6D14-E053-F662850A1439","latestVersionIndicator":"Yes","beginDate":"2019-06-03","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-03","modifiedBy":"MORENOC","dateModified":"2019-11-05","changeDescription":"11/5/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}